<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44-jpm-11-00138">
 <label>44.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Yuan</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Dong</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Lan</surname>
    <given-names>Q.</given-names>
   </name>
  </person-group>
  <article-title>GATA2 promotes glioma progression through EGFR/ERK/Elk-1 pathway</article-title>
  <source>Med. Oncol.</source>
  <year>2015</year>
  <volume>32</volume>
  <fpage>87</fpage>
  <pub-id pub-id-type="doi">10.1007/s12032-015-0522-1</pub-id>
  <pub-id pub-id-type="pmid">25707769</pub-id>
 </element-citation>
</ref>
